Servier
  • ABOUT US
    • About Servier India
    • Patient Care and Support
    • Our commitments
    • Servier Group
  • Our
    therapeutic areas
    • Our therapeutic areas
    • Cardiometabolism and Venous Diseases
    • Oncology
    • Our products
  • Healthcare
    Professionals
  • Corporate
    Social Responsibility
  • Company
    Updates/News
  • CAREERS
  • Contact us
  • Report a side effect
Home > OUR NEWS

Servier India News

Servier deepens commitment in India by establishing a platform dedicated to Single Pill Combinations in Cardiometabolism and Venous Diseases

Read more

Servier India receives marketing authorization for Vorasidenib

10/12/2025

Servier India partners with MedGenome and Strand Life Sciences

11/11/2025

Servier India receives positive recommendation

06/08/2025

Servier India introduces ‘Ivosidenib’ (Tibsovo®) in India

05/06/2025
Servier Logo
  • Sitemap
  • Cookies Policy
  • Privacy Policy
  • CAREERS
  • Contact us
  • Terms of Use
  • Report a side effect
  • Disclosures
© 2026 LES LABORATOIRES SERVIER
This website is intended for Indian residents
‘‘
‘‘

You are leaving www.servier.in

You are about to visit an external website. The content, privacy practices, and terms of use of the destination website may differ from those of www.servier.in.

Please note that MyServier.in is intended exclusively for Healthcare Professionals (HCPs). If you are proceeding to MyServier.in, please continue only if you are a healthcare professional.

By selecting “Continue”, you acknowledge that you are leaving www.servier.in and wish to proceed to the selected website.